RS
Ramandeep Singh Jaj
About Ramandeep Singh Jaj
Data last updated:
Ramandeep Singh Jaj is a Director at Difgen Pharmaceuticals Private Limited (since 2022). The company operates in Research & Development. Difgen Pharmaceuticals Private Limited reported revenue of ₹76.63 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Difgen Pharmaceuticals Private Limited U72100TG2022PTC162383 | Director | 15 Nov 2022 | 2022 | ₹76.63 Cr (FY 2025) | Active |
Board colleagues of Ramandeep Singh Jaj
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amol Ashok Walke | 00664315 | Difgen Pharmaceuticals Private Limited | Director |
| Krishna Chandrasekaran | 10243796 | Difgen Pharmaceuticals Private Limited | Director |
| Narasimhan Sridhar Nagaarjun | 10941810 | Difgen Pharmaceuticals Private Limited | Additional Director |
| Punit Chunilal Thakrar | 00351619 | Difgen Pharmaceuticals Private Limited | Director |
| Santhanakrishnan Srinivasan | 09789679 | Difgen Pharmaceuticals Private Limited | Director |
| Srinivasan Vedantham | 09534573 | Difgen Pharmaceuticals Private Limited | Director |
| Valiveti Brahmaji | 00079255 | Difgen Pharmaceuticals Private Limited | Additional Director |
| Vijay Kumar Vasireddy | 03262782 | Difgen Pharmaceuticals Private Limited | Director |
| Yatin Kirtanlal Desai | 00030719 | Difgen Pharmaceuticals Private Limited | Director |
| Zubin Keki Gandhi | 00664632 | Difgen Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramandeep Singh Jaj
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramandeep Singh Jaj
Ramandeep Singh Jaj currently holds 1 directorship: Difgen Pharmaceuticals Private Limited (Director, since 15 Nov 2022, revenue ₹76.63 Cr (FY 2025)).
Ramandeep Singh Jaj was first appointed on 15 Nov 2022 as Director at Difgen Pharmaceuticals Private Limited.
The current boards of Ramandeep Singh Jaj's companies include Amol Ashok Walke (Difgen Pharmaceuticals Private Limited), Krishna Chandrasekaran (Difgen Pharmaceuticals Private Limited), Narasimhan Sridhar Nagaarjun (Difgen Pharmaceuticals Private Limited), Punit Chunilal Thakrar (Difgen Pharmaceuticals Private Limited), Santhanakrishnan Srinivasan (Difgen Pharmaceuticals Private Limited), Srinivasan Vedantham (Difgen Pharmaceuticals Private Limited), among others.